![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current RPRX market cap is 16.07B. The company's latest EPS is USD 1.8995 and P/E is 14.18.
Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 683.97M | 653.4M | 543.61M | 473.57M | 567.98M |
Operating Income | 513.58M | 363.27M | 153.52M | 468.93M | -87.92M |
Net Income | 340.76M | 227.63M | 72.11M | 494.34M | 4.78M |
Year End December 30 2023 | 2020 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 0 | 2.12B | 2.29B | 2.24B | 2.35B |
Operating Income | -13.79M | 1.64B | 1.41B | 913.92M | 1.5B |
Net Income | 51.28M | 975.04M | 619.73M | 42.83M | 1.13B |
Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 17.07B | 17.12B | 15.86B | 16.38B | 16.13B |
Total Liabilities | 7.25B | 7.31B | 6.27B | 6.3B | 6.27B |
Total Equity | 9.82B | 9.81B | 9.59B | 10.08B | 9.86B |
Year End December 30 2023 | 2020 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 15.07B | 16.02B | 17.52B | 16.81B | 16.38B |
Total Liabilities | 10.03M | 6.12B | 7.27B | 7.29B | 6.3B |
Total Equity | 15.06B | 9.9B | 10.25B | 9.53B | 10.08B |
Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | 1.03B | 1.64B | 2.22B | 2.99B | 664.64M |
Investing | -558.53M | -621.96M | -1.07B | -2.07B | -86.65M |
Financing | -210.37M | -557.37M | -1.92B | -2.15B | -212M |
Year End December 30 2023 | 2020 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | 45.61M | 2.03B | 2.02B | 2.14B | 2.99B |
Investing | -1.87B | -2.76B | -1.87B | -1.03B | -2.07B |
Financing | 1.91B | 1.49B | 385.11M | -944.86M | -2.15B |
Market Cap | 16.07B |
Price to Earnings Ratio | 14.18 |
Price to Sales Ratio | 6.83 |
Price to Cash Ratio | 33.73 |
Price to Book Ratio | 1.6 |
Dividend Yield | 3.05% |
Shares Outstanding | 597.43M |
Average Volume (1 week) | 2.36M |
Average Volume (1 Month) | 2.7M |
52 Week Change | -18.79% |
52 Week High | 33.86 |
52 Week Low | 25.92 |
Spread (Intraday) | 13.82 (34.12%) |
Company Name | Royalty Pharma PLC |
Address |
the pavilions bridgwater road bristol BS13 8AE |
Website | https://www.royaltypharma.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions